{'fraction_non_alphanumeric': 0.02564102564102564, 'fraction_numerical': 0.002136752136752137, 'mean_word_length': 4.819875776397516, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells.

It is difficult to dissect disease-causing T cells and anti-inflammatory T cells in a biopsy specimen obtained at a given time, which would represent a single time point in the development of the lesions. In fixed drug eruption (FDE), the resting lesions long after clinical resolution have many clues to identify the disease-causing T cells, because they contain a large homogeneous population of CD8(+) T cells that are distributed along the epidermal basal layer and have the capacity to rapidly produce large amounts of IFN-gamma. These intraepidermal CD8(+) T cells are likely to be a major actor in epidermal injury observed in FDE lesions. In this review, we ask how they arise and how they cause epidermal injuries, which present with a wide spectrum of clinical manifestations and are often mistaken as signs of other skin disease.